Report Detail
Global Protein and Peptide Therapeutics Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4421317 |
- 09 April, 2022 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
Market Insights
The research report studies the Protein and Peptide Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, the global Protein and Peptide Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.
The global main companies of Protein and Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
The North America Protein and Peptide Therapeutics market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Protein and Peptide Therapeutics landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Injection accounting for % of the Protein and Peptide Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Injection
Oral
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
Regional Scope
This segment of the report offers a thorough regional study of the global Protein and Peptide Therapeutics market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Frequently Asked Questions
Which application segment captured the leading share in the Protein and Peptide Therapeutics market?
How fragmented is the Protein and Peptide Therapeutics market?
Which are the key growth drivers in the Protein and Peptide Therapeutics market?
Which are the top strategies undertaken by the Protein and Peptide Therapeutics market players?
Which technological trends are likely to affect the Protein and Peptide Therapeutics market?
What is the expected Protein and Peptide Therapeutics market size by 2028?
Which companies are dominating the Protein and Peptide Therapeutics market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Protein and Peptide Therapeutics market growth?
Which are the emerging companies in the Protein and Peptide Therapeutics market?
Table of Contents
1 Market Overview of Protein and Peptide Therapeutics
- 1.1 Protein and Peptide Therapeutics Market Overview
- 1.1.1 Protein and Peptide Therapeutics Product Scope
- 1.1.2 Protein and Peptide Therapeutics Market Status and Outlook
- 1.2 Global Protein and Peptide Therapeutics Market Size Overview by Region 2017 VS 2021 VS 2028
- 1.3 Global Protein and Peptide Therapeutics Market Size by Region (2017-2028)
- 1.4 Global Protein and Peptide Therapeutics Historic Market Size by Region (2017-2022)
- 1.5 Global Protein and Peptide Therapeutics Market Size Forecast by Region (2023-2028)
- 1.6 Key Regions, Protein and Peptide Therapeutics Market Size (2017-2028)
- 1.6.1 North America Protein and Peptide Therapeutics Market Size (2017-2028)
- 1.6.2 Europe Protein and Peptide Therapeutics Market Size (2017-2028)
- 1.6.3 Asia-Pacific Protein and Peptide Therapeutics Market Size (2017-2028)
- 1.6.4 Latin America Protein and Peptide Therapeutics Market Size (2017-2028)
- 1.6.5 Middle East & Africa Protein and Peptide Therapeutics Market Size (2017-2028)
2 Protein and Peptide Therapeutics Market Overview by Type
- 2.1 Global Protein and Peptide Therapeutics Market Size by Type: 2017 VS 2021 VS 2028
- 2.2 Global Protein and Peptide Therapeutics Historic Market Size by Type (2017-2022)
- 2.3 Global Protein and Peptide Therapeutics Forecasted Market Size by Type (2023-2028)
- 2.4 Injection
- 2.5 Oral
3 Protein and Peptide Therapeutics Market Overview by Application
- 3.1 Global Protein and Peptide Therapeutics Market Size by Application: 2017 VS 2021 VS 2028
- 3.2 Global Protein and Peptide Therapeutics Historic Market Size by Application (2017-2022)
- 3.3 Global Protein and Peptide Therapeutics Forecasted Market Size by Application (2023-2028)
- 3.4 Cancer
- 3.5 Metabolic Disorders
- 3.6 Central Nervous System
- 3.7 Other
4 Protein and Peptide Therapeutics Competition Analysis by Players
- 4.1 Global Protein and Peptide Therapeutics Market Size by Players (2017-2022)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Protein and Peptide Therapeutics as of 2021)
- 4.3 Date of Key Players Enter into Protein and Peptide Therapeutics Market
- 4.4 Global Top Players Protein and Peptide Therapeutics Headquarters and Area Served
- 4.5 Key Players Protein and Peptide Therapeutics Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Protein and Peptide Therapeutics Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Sanofi
- 5.1.1 Sanofi Profile
- 5.1.2 Sanofi Main Business
- 5.1.3 Sanofi Protein and Peptide Therapeutics Products, Services and Solutions
- 5.1.4 Sanofi Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.1.5 Sanofi Recent Developments
- 5.2 Teva
- 5.2.1 Teva Profile
- 5.2.2 Teva Main Business
- 5.2.3 Teva Protein and Peptide Therapeutics Products, Services and Solutions
- 5.2.4 Teva Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.2.5 Teva Recent Developments
- 5.3 Novo Nordisk
- 5.3.1 Novo Nordisk Profile
- 5.3.2 Novo Nordisk Main Business
- 5.3.3 Novo Nordisk Protein and Peptide Therapeutics Products, Services and Solutions
- 5.3.4 Novo Nordisk Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.3.5 Takeda Recent Developments
- 5.4 Takeda
- 5.4.1 Takeda Profile
- 5.4.2 Takeda Main Business
- 5.4.3 Takeda Protein and Peptide Therapeutics Products, Services and Solutions
- 5.4.4 Takeda Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.4.5 Takeda Recent Developments
- 5.5 Eli Lilly
- 5.5.1 Eli Lilly Profile
- 5.5.2 Eli Lilly Main Business
- 5.5.3 Eli Lilly Protein and Peptide Therapeutics Products, Services and Solutions
- 5.5.4 Eli Lilly Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.5.5 Eli Lilly Recent Developments
- 5.6 AstraZeneca
- 5.6.1 AstraZeneca Profile
- 5.6.2 AstraZeneca Main Business
- 5.6.3 AstraZeneca Protein and Peptide Therapeutics Products, Services and Solutions
- 5.6.4 AstraZeneca Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.6.5 AstraZeneca Recent Developments
- 5.7 Novartis
- 5.7.1 Novartis Profile
- 5.7.2 Novartis Main Business
- 5.7.3 Novartis Protein and Peptide Therapeutics Products, Services and Solutions
- 5.7.4 Novartis Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.7.5 Novartis Recent Developments
- 5.8 AbbVie
- 5.8.1 AbbVie Profile
- 5.8.2 AbbVie Main Business
- 5.8.3 AbbVie Protein and Peptide Therapeutics Products, Services and Solutions
- 5.8.4 AbbVie Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.8.5 AbbVie Recent Developments
- 5.9 Ipsen
- 5.9.1 Ipsen Profile
- 5.9.2 Ipsen Main Business
- 5.9.3 Ipsen Protein and Peptide Therapeutics Products, Services and Solutions
- 5.9.4 Ipsen Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.9.5 Ipsen Recent Developments
- 5.10 Ferring
- 5.10.1 Ferring Profile
- 5.10.2 Ferring Main Business
- 5.10.3 Ferring Protein and Peptide Therapeutics Products, Services and Solutions
- 5.10.4 Ferring Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.10.5 Ferring Recent Developments
- 5.11 Merck
- 5.11.1 Merck Profile
- 5.11.2 Merck Main Business
- 5.11.3 Merck Protein and Peptide Therapeutics Products, Services and Solutions
- 5.11.4 Merck Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.11.5 Merck Recent Developments
- 5.12 The Medicines
- 5.12.1 The Medicines Profile
- 5.12.2 The Medicines Main Business
- 5.12.3 The Medicines Protein and Peptide Therapeutics Products, Services and Solutions
- 5.12.4 The Medicines Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.12.5 The Medicines Recent Developments
- 5.13 J & J
- 5.13.1 J & J Profile
- 5.13.2 J & J Main Business
- 5.13.3 J & J Protein and Peptide Therapeutics Products, Services and Solutions
- 5.13.4 J & J Protein and Peptide Therapeutics Revenue (US$ Million) & (2017-2022)
- 5.13.5 J & J Recent Developments
6 North America
- 6.1 North America Protein and Peptide Therapeutics Market Size by Country (2017-2028)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Protein and Peptide Therapeutics Market Size by Country (2017-2028)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
8 Asia-Pacific
- 8.1 Asia-Pacific Protein and Peptide Therapeutics Market Size by Region (2017-2028)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 India
- 8.6 Australia
- 8.7 China Taiwan
- 8.8 Indonesia
9 Latin America
- 9.1 Latin America Protein and Peptide Therapeutics Market Size by Country (2017-2028)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Argentina
10 Middle East & Africa
- 10.1 Middle East & Africa Protein and Peptide Therapeutics Market Size by Country (2017-2028)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
11 Protein and Peptide Therapeutics Market Dynamics
- 11.1 Protein and Peptide Therapeutics Industry Trends
- 11.2 Protein and Peptide Therapeutics Market Drivers
- 11.3 Protein and Peptide Therapeutics Market Challenges
- 11.4 Protein and Peptide Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Protein and Peptide Therapeutics. Industry analysis & Market Report on Protein and Peptide Therapeutics is a syndicated market report, published as Global Protein and Peptide Therapeutics Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Protein and Peptide Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
